Gleevec 400 MG tablet 10S
Ended Awarded
- Contract number
- SPE2DB25FW98A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,828
Award facts
- Contract value 100% obligated
- $22,827.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,827.51 to AmerisourceBergen Drug Corp for the supply of Gleevec 400 mg tablets (10-count units) on June 4, 2025, with an ultimate completion date of June 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Gleevec is a targeted cancer therapy used primarily in the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors, representing a critical pharmaceutical supply for military and federal healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical vendor agreement enables the contractor to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated consistent capability to fulfill federal procurement requirements through competitive award of diverse medical commodity orders.
Quick answers
Who was awarded contract SPE2DB25FW98A?
SPE2DB25FW98A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FW98A worth?
The government has obligated $22,828 on SPE2DB25FW98A.
Is contract SPE2DB25FW98A an order under another contract?
Yes. SPE2DB25FW98A is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW98A competed?
The extent of competition for SPE2DB25FW98A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award